טוען...
FFA4/GPR120: Pharmacology and Therapeutic Opportunities
Free Fatty Acid receptor 4 (FFA4), also known as GPR120, is a G-protein-coupled receptor (GPCR) responsive to long-chain fatty acids that is attracting considerable attention as a potential novel therapeutic target for the treatment of type 2 diabetes mellitus (T2DM). Although no clinical studies ha...
שמור ב:
| הוצא לאור ב: | Trends Pharmacol Sci |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Published By Elsevier In Association With The International Union Of Pharmacology
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5582618/ https://ncbi.nlm.nih.gov/pubmed/28734639 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tips.2017.06.006 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|